BRNS
Price
$0.92
Change
+$0.04 (+4.55%)
Updated
Jun 26 closing price
Capitalization
37.21M
41 days until earnings call
IMVT
Price
$16.39
Change
+$0.64 (+4.06%)
Updated
Jun 26 closing price
Capitalization
2.8B
40 days until earnings call
Interact to see
Advertisement

BRNS vs IMVT

Header iconBRNS vs IMVT Comparison
Open Charts BRNS vs IMVTBanner chart's image
Barinthus Biotherapeutics
Price$0.92
Change+$0.04 (+4.55%)
Volume$2.88K
Capitalization37.21M
Immunovant
Price$16.39
Change+$0.64 (+4.06%)
Volume$957.7K
Capitalization2.8B
BRNS vs IMVT Comparison Chart in %
Loading...
BRNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BRNS vs. IMVT commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRNS is a Buy and IMVT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (BRNS: $0.92 vs. IMVT: $16.39)
Brand notoriety: BRNS and IMVT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BRNS: 8% vs. IMVT: 79%
Market capitalization -- BRNS: $37.21M vs. IMVT: $2.8B
BRNS [@Biotechnology] is valued at $37.21M. IMVT’s [@Biotechnology] market capitalization is $2.8B. The market cap for tickers in the [@Biotechnology] industry ranges from $301.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRNS’s FA Score shows that 1 FA rating(s) are green whileIMVT’s FA Score has 0 green FA rating(s).

  • BRNS’s FA Score: 1 green, 4 red.
  • IMVT’s FA Score: 0 green, 5 red.
According to our system of comparison, BRNS is a better buy in the long-term than IMVT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BRNS’s TA Score shows that 3 TA indicator(s) are bullish while IMVT’s TA Score has 7 bullish TA indicator(s).

  • BRNS’s TA Score: 3 bullish, 6 bearish.
  • IMVT’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, IMVT is a better buy in the short-term than BRNS.

Price Growth

BRNS (@Biotechnology) experienced а +6.03% price change this week, while IMVT (@Biotechnology) price change was +3.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.59%. For the same industry, the average monthly price growth was +34.25%, and the average quarterly price growth was +14.95%.

Reported Earning Dates

BRNS is expected to report earnings on Aug 07, 2025.

IMVT is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+3.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMVT($2.8B) has a higher market cap than BRNS($37.2M). BRNS YTD gains are higher at: -23.634 vs. IMVT (-33.831). BRNS has higher annual earnings (EBITDA): -58.89M vs. IMVT (-437.78M). IMVT has more cash in the bank: 714M vs. BRNS (99.1M). IMVT has less debt than BRNS: IMVT (98K) vs BRNS (11.9M). BRNS has higher revenues than IMVT: BRNS (15M) vs IMVT (0).
BRNSIMVTBRNS / IMVT
Capitalization37.2M2.8B1%
EBITDA-58.89M-437.78M13%
Gain YTD-23.634-33.83170%
P/E RatioN/AN/A-
Revenue15M0-
Total Cash99.1M714M14%
Total Debt11.9M98K12,143%
FUNDAMENTALS RATINGS
IMVT: Fundamental Ratings
IMVT
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
27

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BRNSIMVT
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
77%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
77%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 29 days ago
78%
Bullish Trend 21 days ago
77%
Declines
ODDS (%)
Bearish Trend 7 days ago
87%
Bearish Trend 4 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
BRNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AAAPX12.24N/A
N/A
DWS RREEF Real Assets C
VDVIX13.91N/A
N/A
Vanguard Developed Markets Index Inv
HEONX16.87N/A
N/A
Hartford Climate Opportunities C
ETADX19.21N/A
N/A
Eventide Dividend Growth A
SGIGX33.10N/A
N/A
Steward Global Equity Income Fund R6

BRNS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRNS has been loosely correlated with SLNO. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if BRNS jumps, then SLNO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRNS
1D Price
Change %
BRNS100%
+4.43%
SLNO - BRNS
56%
Loosely correlated
-2.06%
NGNE - BRNS
51%
Loosely correlated
-1.84%
NEUP - BRNS
50%
Loosely correlated
-2.86%
IMVT - BRNS
48%
Loosely correlated
+4.06%
TARA - BRNS
35%
Loosely correlated
-2.61%
More

IMVT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMVT has been loosely correlated with ROIV. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if IMVT jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMVT
1D Price
Change %
IMVT100%
+4.06%
ROIV - IMVT
61%
Loosely correlated
+1.75%
OCUL - IMVT
51%
Loosely correlated
+2.94%
CGON - IMVT
50%
Loosely correlated
+0.04%
IDYA - IMVT
49%
Loosely correlated
+1.27%
XENE - IMVT
49%
Loosely correlated
+1.39%
More